Market Guru Weighs in on 2024: Small Caps, Large Caps, GLP-1, and More

Paul La Monica is as veteran as veteran gets in the financial and economic journalism space. His 20+ years at CNN was just part of his career – and he’s still going strong after nearly 30 years in the biz, and has his finger on the pulse of the US economy in a way that few do. 
Paul joins James to talk about recessions (how they’re “good,” or at least necessary), the small cap-vs.-large cap valuation difference and how it may converge, GLP-1 agonists like Ozempic and whether the investment trend is played out or has room to run, as well as AI’s effect on journalism and the decline of traditional media.

Watch Paul and James discuss all of this – as well as the happiest moment in Paul’s life – below:

This article is for informational purposes only and is neither investment advice nor a solicitation to buy or sell securities. Investing carries inherent risks. Always conduct thorough research or consult with a financial expert before making any investment decisions. Neither the author nor BBAE has a position in any investment mentioned.

Related Posts
BBAE Blueprint

First Deposit at BBAE? Up to $400 Bonus!

Tailored insights, powerful tools. Automatic bonus at signup.
Get Started with BBAE Now!